Healthcare
Eli Lilly and InnoCare Sign Drug-Discovery Pact Worth Up to $3.35 Billion
Eli Lilly and China’s InnoCare have formed a research and licensing partnership covering up to five targets, adding to a…
Eli Lilly and China’s InnoCare have formed a research and licensing partnership covering up to five targets, adding to a…
Novo Nordisk has licensed Nanexa’s PharmaShell platform in a deal worth up to €1.165 billion, targeting monthly or potentially quarterly…
Roche’s agreement with Atavistik Bio targets cardiovascular, kidney and metabolic disease, extending Big Pharma’s push to source novel drug platforms…
Rio Health has raised $4.5 million in a pre-Series A round led by Version One Ventures to scale its AI-powered…
Read next